| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Common Stock | 191K | $420K | $2.20 | Jan 15, 2025 | Direct |
| Lyell Immunopharma, Inc. | Chief Medical Officer | Common Stock | 21.9K | $8.76K | $0.40 | Jun 9, 2025 | Direct |
| Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Stock Option (right to buy) | 118K | Jan 3, 2025 | Direct | ||
| Lyell Immunopharma, Inc. | Chief Medical Officer | Option (right to buy) | 43.8K | Jun 9, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Jun 9, 2025 | 2 | $0 | 4 | Jun 11, 2025 | Chief Medical Officer |
| LYEL | Lyell Immunopharma, Inc. | Jun 9, 2025 | 0 | $0 | 3 | Jun 11, 2025 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jan 15, 2025 | 1 | -$19K | 4 | Jan 17, 2025 | Chief Medical Officer, Head of Research & Development |
| NKTX | Nkarta, Inc. | Jan 3, 2025 | 2 | $0 | 4 | Jan 7, 2025 | Chief Medical Officer, Head of Research & Development |
| NKTX | Nkarta, Inc. | Aug 21, 2024 | 1 | -$6.91K | 4 | Aug 23, 2024 | Chief Medical Officer, Head of Research & Development |
| NKTX | Nkarta, Inc. | Jul 15, 2024 | 2 | $0 | 4 | Jul 31, 2024 | Chief Medical Officer, Head of Research & Development |
| NKTX | Nkarta, Inc. | Jun 18, 2024 | 1 | -$2.55K | 4 | Jun 20, 2024 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jan 16, 2024 | 1 | -$31K | 4 | Jan 18, 2024 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jan 4, 2024 | 2 | $0 | 4 | Jan 8, 2024 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Aug 21, 2023 | 1 | -$2.44K | 4 | Aug 23, 2023 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jun 20, 2023 | 1 | -$2.13K | 4 | Jun 22, 2023 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jan 13, 2023 | 3 | -$961 | 4 | Jan 18, 2023 | Chief Medical Officer |
| NKTX | Nkarta, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 10, 2023 | Chief Medical Officer |